Calcitriol ameliorates cisplatin-induced hepatorenal toxicity via regulation of Nrf2-Mrp2/p38 MAPK signaling in mice
International Journal of Immunopathology and Pharmacology · 2024
DOI: 10.1177/03946320241306276 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Immunopathology and Pharmacology, 2024. Verfasst von Mohamed A Morsy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Hofuf, Al-Ahsa, Saudi Arabia. Hauptthemen laut MEDLINE: Cisplatin, NF-E2-Related Factor 2, p38 Mitogen-Activated Protein Kinases, Calcitriol. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: King Abdulaziz City for Science and Technology.
Abstract (Originalsprache)
Despite being one of the most frequently used chemotherapy agents, cisplatin exhibits substantial hepatorenal injury by triggering oxidative stress, inflammation, and apoptosis pathways. The current investigation studied the possible protective effects of calcitriol on cisplatin-induced hepatorenal toxicity. Mice were divided randomly as follows: control group, calcitriol group (received calcitriol 5 µg/kg, p.o. for 14 days), cisplatin group (received a single i.p. injection of cisplatin 10 mg/kg on the 10th day), and calcitriol + cisplatin group (received calcitriol 5 µg/kg, p.o. for 14 days and cisplatin 10 mg/kg, i.p. on the 10th day). The possible interaction between calcitriol and cisplatin on cell viability was tested in HepG2 cells by MTT assay. Hepatorenal toxicity induced by cisplatin was reversed by calcitriol, as evidenced by improved histological examinations and liver and kidney function tests. In addition, calcitriol counteracted oxidative stress and enhanced Nrf2 and Mrp2 expression in the liver and kidney while suppressing levels of p38 MAPK in cisplatin-treated mice. Calcitriol also inhibited cisplatin-induced hepatic and renal inflammation, as determined by suppressing TNF-α and enhancing IL-10 levels. By downregulating caspase-3, calcitriol also promoted liver and kidney tissue survival in mice treated with cisplatin. Moreover, cisplatin’s cytotoxic effects were significantly potentiated when calcitriol was combined with cisplatin. The current study showed that calcitriol protects against cisplatin-induced hepatorenal injury by suppressing oxidative stress, inflammation, and apoptosis, which the Nrf2-Mrp2/p38 MAPK pathway might regulate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Hofuf, Al-Ahsa, Saudi Arabia.
- Department of Pharmacology, Faculty of Medicine, Minia University, El-Minia, Egypt.
- Department of Pharmacology & Toxicology, Faculty of Pharmacy, Minia University, El-Minia, Egypt.
- Department of Histology and Cell Biology, Faculty of Medicine, Minia University, El-Minia, Egypt.
- Department of Biochemistry, Faculty of Medicine, Minia University, El-Minia, Egypt.
ORCID-Profile: Mohamed A Morsy, Rania Abdel-Latif
Förderung
- King Abdulaziz City for Science and Technology
Zitieren
APA
Morsy, M. A., Abdel-Latif, R., Ibrahim, M. F., Marey, H., & Abdel-Gaber, S. A. (2024). Calcitriol ameliorates cisplatin-induced hepatorenal toxicity via regulation of Nrf2-Mrp2/p38 MAPK signaling in mice. International Journal of Immunopathology and Pharmacology. https://doi.org/10.1177/03946320241306276
Vancouver
Morsy MA, Abdel-Latif R, Ibrahim MF, Marey H, Abdel-Gaber SA. Calcitriol ameliorates cisplatin-induced hepatorenal toxicity via regulation of Nrf2-Mrp2/p38 MAPK signaling in mice. International Journal of Immunopathology and Pharmacology. 2024. doi:10.1177/03946320241306276
BibTeX
@article{Morsy2024,
author = {Morsy, Mohamed A and Abdel-Latif, Rania and Ibrahim, Manar Fg and Marey, Heba and Abdel-Gaber, Seham A},
title = {Calcitriol ameliorates cisplatin-induced hepatorenal toxicity via regulation of Nrf2-Mrp2/p38 MAPK signaling in mice},
journal = {International Journal of Immunopathology and Pharmacology},
year = {2024},
doi = {10.1177/03946320241306276}
}
EUVIMED